1. Hong Kong Stocks

  2. •

    Consumer durables

  3. •

    Recreational products
China Healthwise Holdings Ltd.

China Healthwise Holdings Ltd.

HHKEX:348
0.07
HKD
0.00
(0.00%)
119.42MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.62
0.36
0.7
0.6
0.54
0.81
0.53
0.18
0.22
0.18
0.19
0.15
0.13
- -
Basic EPS, GAAP
0.01
0.01
0.03
-0.14
-0.41
-0.27
-0.11
-0.03
-0.13
-0.07
-0.17
-0.05
- -
- -
Free Cash Flow per Basic Share
-0.01
-0.09
-0.14
-0.05
-0.2
-0.24
-0.28
0.01
0.05
-0.04
0.02
- -
0.02
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.41
1.03
1.12
0.98
0.55
0.46
0.53
0.38
0.25
0.18
0.01
-0.02
-0.03
-0.02
Tangible Book Value per Share
1.4
0.83
0.92
0.87
0.54
0.45
0.53
0.38
0.25
0.18
0.01
-0.02
-0.03
-0.02
Basic Weighted Avg Shares
336
538
558
585
592
691
845
775
770
770
770
770
770
770
Sales/Revenue/Turnover
209
194
389
353
319
561
452
138
170
142
146
114
100
- -
Operating Margin (%)
0.34
-8.54
-6.12
-23.38
-43.78
-6.54
-0.82
1.44
15.77
-9.09
-3.49
-15.94
-16.47
- -
Depreciation Expense
4
4
9
12
18
20
4
11
4
3
6
7
6
- -
Net Income, GAAP
2
5
17
-81
-242
-186
-95
-25
-103
-54
-135
-40
-3
- -
Effective Tax Rate (%)
- -
- -
61.47
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
1.06
2.73
4.37
-23.05
-75.79
-33.16
-21.11
-18.3
-60.59
-38.21
-91.96
-35.47
-2.62
- -
Working Capital
448
422
416
350
-9
33
390
238
82
200
-3
40
-25
40
LT Debt
- -
8
15
- -
- -
- -
101
88
1
74
2
66
2
66
Total Equity
488
568
623
561
291
274
393
296
193
139
4
-18
-21
-18
Return on Invested Capital (%)
- -
- -
-0.18
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
4.51
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
0.88
1
2.83
-13.41
-53.25
-56.83
-24.35
-6.71
-42.12
-32.72
-188.13
- -
- -
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
107
109
38
LT Borrowings
- -
- -
63
LT Finance Leases
2
1
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
770
770
770
Market Capitalization
32
49
119

Working Capital

HKD

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
140
102
113
Cash, Cash Equivalents & STI
54
42
45
Accounts Receivable, Net
6
4
4
Inventories
56
43
50
Total Current Liabilities
143
133
73
Payables & Accruals
- -
- -
- -
ST Debt
107
109
38
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-70.86%
-132.71%
14.21%
Free Cash Flow
169.22%
286.06%
1,383.63%
Net Income, GAAP
-27.97%
49.11%
-93.53%
Sales/Revenue/Turnover
-5.7%
-4.96%
-12.34%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
146
2024
- -
- -
114
2025
- -
- -
100

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.17
2024
- -
- -
-0.05
2025
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Hong Wai Lei
Full Time Employees
76
Sector
Consumer durables
Industry
Recreational products
Address
West Tower Hong Kong Hong Kong
IPO Date
Sep 30, 1997
Website
healthwisehk.com
Similar Companies
Nintendo Co., Ltd. (TSE:7974)
Amer Sports, Inc. (NYSE:AS)
Hasbro, Inc. (NASDAQ:HAS)
Twin Vee PowerCats Co. (NASDAQ:VEEE)
Mattel, Inc. (NASDAQ:MAT)
Bandai Namco Holdings Inc. (TSE:7832)
Business
China Healthwise Holdings Limited (0348.HK) is an investment holding company principally engaged in the sale of Chinese health products, money lending business, and investment in financial instruments. The group sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers through its subsidiary Nam Pei Hong Sum Yung Drugs Company Limited, which trades and retails Sum Yung (參茸) and dried seafood under the Nam Pei Hong (南北行) brand via 10 retail shops in Hong Kong; it also provides unsecured money loans at interest rates of 8%-13% per annum and invests in listed equity securities in Hong Kong such as Huanxi Media Group Limited, Ocean Line Port Development Limited, and Yunfeng Financial Group Limited, as well as unlisted equities. Operations are based primarily in Hong Kong with some presence in the People's Republic of China, targeting wholesalers, retailers, and individual customers in the health products and financial sectors. Incorporated in 1997 and headquartered at Unit 1209, Shun Tak Centre, West Tower, 168-200 Connaught Road Central, Hong Kong, the company, formerly known as Haier Healthwise Holdings Limited, changed its name in January 2017. Recent developments include the adoption of a new share option scheme in August 2024 valid until 2034; extension of a HK$9 million revolving loan facility to the ultimate holding company of a substantial shareholder during 2024 and 2025 without new loans to other customers; recognition of a HK$1.4 million impairment loss on right-of-use assets for underperforming retail shops in the first half of 2025; and receipt of HK$16.8 million funding from Heng Tai Finance Limited in late 2024.